CRS Strangle Strategy

CRS (Carpenter Technology Corporation), in the Industrials sector, (Manufacturing - Metal Fabrication industry), listed on NYSE.

Carpenter Technology Corporation engages in the manufacture, fabrication, and distribution of specialty metals in the United States, Europe, the Asia Pacific, Mexico, Canada, and internationally. It operates in two segments, Specialty Alloys Operations and Performance Engineered Products. The company offers specialty alloys, including titanium alloys, powder metals, stainless steels, alloy steels, and tool steels, as well as additives, and metal powders and parts. It serves aerospace, defense, medical, transportation, energy, industrial, and consumer markets. The company was founded in 1889 and is headquartered in Philadelphia, Pennsylvania.

CRS (Carpenter Technology Corporation) trades in the Industrials sector, specifically Manufacturing - Metal Fabrication, with a market capitalization of approximately $21.68B, a trailing P/E of 45.54, a beta of 1.24 versus the broader market, a 52-week range of 219.58-475.69, average daily share volume of 716K, a public-listing history dating back to 1987, approximately 5K full-time employees. These structural characteristics shape how CRS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.24 places CRS roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 45.54 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple. CRS pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a strangle on CRS?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current CRS snapshot

As of May 15, 2026, spot at $409.23, ATM IV 48.50%, IV rank 39.83%, expected move 13.90%. The strangle on CRS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this strangle structure on CRS specifically: CRS IV at 48.50% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 13.90% (roughly $56.90 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CRS expiries trade a higher absolute premium for lower per-day decay. Position sizing on CRS should anchor to the underlying notional of $409.23 per share and to the trader's directional view on CRS stock.

CRS strangle setup

The CRS strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CRS near $409.23, the first option leg uses a $430.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CRS chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CRS shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$430.00$16.75
Buy 1Put$390.00$14.50

CRS strangle risk and reward

Net Premium / Debit
-$3,125.00
Max Profit (per contract)
Unbounded
Max Loss (per contract)
-$3,125.00
Breakeven(s)
$358.75, $461.25
Risk / Reward Ratio
Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

CRS strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on CRS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price% From SpotP&L at Expiration
$0.01-100.0%+$35,874.00
$90.49-77.9%+$26,825.81
$180.97-55.8%+$17,777.62
$271.46-33.7%+$8,729.43
$361.94-11.6%-$318.76
$452.42+10.6%-$883.05
$542.90+32.7%+$8,165.15
$633.38+54.8%+$17,213.34
$723.87+76.9%+$26,261.53
$814.35+99.0%+$35,309.72

When traders use strangle on CRS

Strangles on CRS are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CRS chain.

CRS thesis for this strangle

The market-implied 1-standard-deviation range for CRS extends from approximately $352.33 on the downside to $466.13 on the upside. A CRS long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current CRS IV rank near 39.83% is mid-range against its 1-year distribution, so the IV signal is neutral; the strangle thesis on CRS should anchor more to the directional view and the expected-move geometry. As a Industrials name, CRS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CRS-specific events.

CRS strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CRS positions also carry Industrials sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CRS alongside the broader basket even when CRS-specific fundamentals are unchanged. Always rebuild the position from current CRS chain quotes before placing a trade.

Frequently asked questions

What is a strangle on CRS?
A strangle on CRS is the strangle strategy applied to CRS (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With CRS stock trading near $409.23, the strikes shown on this page are snapped to the nearest listed CRS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are CRS strangle max profit and max loss calculated?
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the CRS strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 48.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$3,125.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a CRS strangle?
The breakeven for the CRS strangle priced on this page is roughly $358.75 and $461.25 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CRS market-implied 1-standard-deviation expected move is approximately 13.90%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on CRS?
Strangles on CRS are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CRS chain.
How does current CRS implied volatility affect this strangle?
CRS ATM IV is at 48.50% with IV rank near 39.83%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related CRS analysis